Multiple Myeloma News Monitoring

Isatuximab Combo Earns Chinese Approval in R/R Multiple Myeloma

China’s National Medical Products Administration (NMPA) has approved isatuximab-irfc (Sarclisa) plus pomalidomide (Pomalyst) and dexamethasone for adults with multiple myeloma who were previously treated with at least 1 therapy including lenalidomide ( …

Talquetamab and Teclistamab Achieve Deep, Durable Responses in Patients With Relapsed, Refractory Multiple Myeloma

Talquetamab (Talvey; Janssen Biotech Inc) and teclistamab (Tecvayli; Janssen Biotech Inc) combination therapy achieved deep, durable responses in patients with relapsed or refractory multiple myeloma (RRMM), according to data from the RedirecTT-1 trial ( …

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd announced an option to license agreement to develop SIM0500, an investigational new drug candidate. SIM0500 is currently in Phase 1 clinical trials in patients with relapsed or …

Dr Ali on the Need for Novel Targets Beyond BCMA in Multiple Myeloma

“[BCMA and GPRC5D] are great [targets], but we need to increase the repertoire. The challenge is finding targets [that are] often expressed on myeloma cells, are expressed in a high density, and don’t disappear when you put them under pressure with …

Dr Ruella on Improving Access to CAR T-Cell Therapy for Minority Populations in Multiple Myeloma

"We need to act both on the patient side and the healthcare provider side, in the sense that we need to educate providers to be aware of potential unconscious biases. At the same time, we also need to [ask ourselves:] does the patient have the …

AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn

AbbVie and Simcere Zaiming have announced a partnership worth over $1bn to develop an investigational drug candidate for multiple myeloma. The companies have entered into an option to licence agreement for Simcere Zaiming’s SIM0500, a trispecific antibody …

New innovative local treatment for osteolytic bone disease in multiple myeloma

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These lesions cause severe pain and fractures that often …

Hungarian multiple myeloma patients facing serious delays in plasma cancer diagnosis

In Hungary, 21% of multiple myeloma patients wait over a year for diagnosis, while 15% receive confirmation after at least six months. Optimising patient pathways, ensuring early diagnosis, and improving access to effective treatments are key to improving …

Dr van den Brink on a High-Fiber Dietary Intervention in Smoldering Multiple Myeloma

Marcel van den Brink, MD, PhD, director, the Division of Hematologic Malignancies, City of Hope, discusses findings from the NUTRIVENTION3 trial (NCT05640843) evaluating a high-fiber dietary intervention designed to assess its impact on precursor plasma …

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement to develop SIM0500, an …

Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma ( …

China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one …

Isatuximab Plus Pomalidomide and Dexamethasone Receives Approval in China for Relapsed/Refractory Multiple Myeloma

The Chinese National Medical Products Administration (NMPA) has approved isatuximab-irfc (Sarclisa) plus pomalidomide (Pomalyst) and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least 1 prior line of …

Meet Northwell's inaugural chief of multiple myeloma

David Chung, MD, PhD, is one of Northwell Health's newest subspecialists in cancer care. After 20 years in academic medicine at Memorial Sloan Kettering, Dr. Chung joined the New Hyde Park, N.Y.-based system in December as the inaugural system chief of …

Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one …

Vaxil Bio Proposed Reverse Takeover With Green Date Terminated

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States  NESS-ZIONA, Israel, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Vaxil Bio …

Sanofi announces positive phase 3 results for subcutaneous Sarclisa in multiple myeloma

Sanofi has shared positive results from a late-stage study investigating a subcutaneous formulation of its anti-CD38 therapy Sarclisa (isatuximab) in multiple myeloma (MM) patients. The ongoing IRAKLIA study has been comparing SC Sarclisa, delivered at a …

Second-Line Treatment for R/R Multiple Myeloma: Who Is the “Right Patient”?

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory ...

Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma Approval based on positive pivotal ICARIA-MM phase 3 study using the China-based IsaFiRsT real-world study as bridging data, which …

Compounding Pharmacies Market Size to Worth USD 13.6 billion by 2030 With a 6.8 % CAGR by Exactitude Consultancy

Compounding Pharmacies Market include Advanced Pharmacy, Athenex, B. Braun Melsungen Ag, Dougherty’s Pharmacy Inc CALIFORNIA, CA, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- The report is a well-researched data presentation that …

Global Generic Injectable Market Set to Soar, Projected to Reach USD 322,433.1 Million by 2033 at a CAGR of 11.6% | FMI

Tech advancements, robust pipelines, and portfolio expansions drive the UK generic injectable market, with acquisitions boosting nonexclusive clean injectables. NEWARK, DE, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- The global generic …

Orthopedic Anchor Market Expected to Hit USD 3.2 Billion by 2032 with a Remarkable 5.48% CAGR

The Global Orthopedic Anchor Market Industry is primarily driven by the rising prevalence of orthopedic conditions worldwide. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- 𝚆𝙶𝚁 released the report titled "orthopedic …

Liquid Bandage Spray Market Set to Grow at an Impressive CAGR of 4.56% Through 2032 | 3M, Johnson&Johnson, Cardinal

sports and outdoor activities, is a key driver of the Global Liquid Bandage Spray Market Industry. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- 𝚆𝙶𝚁 released the report titled "liquid bandage spray Market have 2025- …

Oral Hygiene Devices Market Poised to Growth USD 56 Billion by 2032 with Thriving CAGR of 3.32% | Rising Demands

The dental diseases, such as cavities, gum disease, and oral cancer, is a major driver of the growth of the Global Oral Hygiene Devices Market Industry. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- 𝚆𝙶𝚁 released the report …

Creative Diagnostics Introduces Innovative Antibodies for BNP, NT-proBNP, and proBNP in Cardiovascular Diagnostics

Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- Creative Diagnostics, a leading …

CD Bioparticles Launches Silica Spin Column for Nucleic Acid Extraction

CD Bioparticles announces its comprehensive line of Silica Spin Columns for efficient and reliable isolation of DNA & RNA. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- With years of experience in the pharmaceutical and …

CD Bioparticles Introduces Comprehensive Solutions for Exosome DNA & RNA Isolation

CD Bioparticles announces its comprehensive portfolio of products for the isolation and extraction of Exosome DNA & RNA. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- CD Bioparticles, a leading manufacturer and supplier …

STEMart Announces Comprehensive Materials Testing Solutions for Improved Product Performance

STEMart announced its comprehensive suite of materials testing solutions that cater to a wide range of industries and applications. NEW YORK, NY, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- STEMart, a US-based provider of comprehensive …

Medical Gloves Market Expected to Achieve a Strong 7.3% CAGR, to Reach USD 22.3 Billion by 2032

The healthcare landscape in 2025 is poised for a transformative shift, driven by innovation and collaboration. US, AL, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Market Research Future Latest Industry Insights on Medical Gloves Market …

Autism Disorder and Treatment Market Set to Grow at an Impressive CAGR of 7.20% Through 2032 | USD 12.21 Billion

Autism Disorder and Treatment Market Insights: Increasing prevalence of autism spectrum disorder (ASD) boosts therapeutic demand US, VA, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Market Research Future Latest Industry Insights on “ …

Atticus Publishing Presents: Eduardo Saldaña Cantú’s El Duelo (The Duel)

"A Story of Faith, Resilience, and Hope based on Untold Histories Along the Rio Grande" SAN FRANCISCO, CA, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- Atticus Publishing proudly presents a recent work by Eduardo Saldaña Cantú …

Preclinical CRO Market Anticipated to Reach USD 20.06 Billion, at a Notable 7.50% CAGR by 2032

Preclinical CRO Market Insights: Expanding due to pharmaceutical R&D outsourcing trends US, CA, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Market Research Future Latest Industry Insights on Preclinical CRO Market Research By …

Wearable Medical Device Market Expected to Hit USD 87.25 Billion by 2032 with a Remarkable 10.80% CAGR

Wearable Medical Device Market Insights: Strong growth supported by demand for continuous health monitoring and fitness tracking. US, AL, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Market Research Future Latest Industry Insights on “ …

National Mental Health Alliance Day- Honolulu, Hawaii

HONOLULU, HI, UNITED STATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Join us in Honolulu Hawaii at the National Mental Health Alliance Day as we provide presentations on the following topics: Mental Health, Addiction, Fentanyl, and Human …

Dynamic Researcher and Regenerative Scientist Dr. Benjamin Arthur Recently Featured on Close Up Radio

ALPHARETTA, GA, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- Dr. Benjamin Arthur is a research scientist at the forefront of one of the most exciting discoveries of our times: the value of stem cells in medicinal treatment, prevention, …

Arab Health marks its 50th-anniversary celebration with the launch of four new conferences

The conferences, part of Arab Health Congress 2025, will welcome 250 speakers and host more than 110 sessions, with over 3,400 delegates expected DUBAI, UNITED ARAB EMIRATES, January 17, 2025 /⁨EINPresswire.com⁩/ -- Arab Health 2025, the Middle …

VAO Launches Game-Changing AI to Instantly Turn Phone Calls into Orders and Quotes

New AI phone-call capture slashes manual entry time, ensures accuracy, and elevates customer service for manufacturers and wholesalers. SAN FRANCISCO , CA, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- VAO, a leader in AI-driven Order …

TravelingWiki Addresses Gathered Attendees at Iowa State Capitol to Support 2025 Autism Advocacy & Acceptance Day

In Advance of TravelingWiki’s Collaboration with Autism Society of Iowa on Iowa Wild Autism Awareness Pro Hockey Game, TravelingWiki Speaks at Iowa Capitol DES MOINES, IA, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- Following rapid …

AppZen Focuses its AI Platform on Powering Autonomous Finance Operations for Global Organizations

Mastermind AI Automation Platform transforms finance operations for enterprise companies with comprehensive solutions for AP, T&E, and corporate card management SAN JOSE, CA, UNITED STATES, January 16, 2025 /⁨EINPresswire.com⁩/ -- AppZen, the …